Is chronic pain on your cardiovascular risk checklist? Learn why this overlooked factor deserves attention in your preventive ...

A young woman shares her emotional journey with hidradenitis suppurativa, chronic skin inflammation for which treatments are ...

Recently, testing of treatments known as cellular therapies, often called “CAR-T,” has shown promise beyond the medications ...

A drug licensed from Pfizer will be submitted to the FDA next year after study results showed it reduced dermatomyositis ...

ERS/EULAR guidelines outline best practices for diagnosis, monitoring, and treatment of connective tissue disease-related ILD ...

Pain is complex and often connected to lifestyle factors such as stress, sleep, and diet. Herbs can be part of a holistic ...

The Food and Drug Administration has approved a device that uses electrical stimulation to reduce inflammation from rheumatoid arthritis.

A team from Shriners Children's and Washington University in St. Louis are investigating a new method for personalizing ...

Patients with rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus frequently face anxiety and ...

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 Filing ...

Results show that GLP-1s may address rheumatoid arthritis (RA) symptoms, independent of established weight loss and cardiac benefits, by reducing the systemic, chronic inflammation associated with RA.